Начало › Наднормено тегло › Флорида › Orlando
Клинични проучвания за Наднормено тегло в Orlando, FL
27 проучвания за Наднормено тегло търсят участници в обекти в и около Orlando (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Набиране на участнициФаза 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Набиране на участници
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Набиране на участнициФаза 1Здравите доброволци са добре дошли
- Kailera Clinical Site, Orlando
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Набиране на участнициФаза 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Набиране на участнициФаза 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · на 5 мили
- K2 Medical Research Maitland LLC, Main Office, Maitland · на 6 мили
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Набиране на участнициФаза 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Набиране на участнициФаза 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Набиране на участнициФаза 3
- Florida Inst For Clin Res LLC, Orlando
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Набиране на участнициФаза 3
- Headlands Research Orlando, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Набиране на участнициФаза 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Набиране на участнициФаза 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Набиране на участнициФаза 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Набиране на участнициФаза 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · на 5 мили
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Набиране на участнициФаза 3
- Research Site, Ocoee · на 10 мили
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Набиране на участнициФаза 3
- West Orange Endocrinology, Ocoee · на 10 мили
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Набиране на участнициФаза 3
- Conquest Research, Winter Park · на 5 мили
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Набиране на участнициФаза 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Набиране на участнициФаза 3
- AURORA-1 Clinical Site, Winter Park · на 5 мили
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Набиране на участнициФаза 3
- AURORA-2 Clinical Site, Winter Park · на 5 мили
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Набиране на участници
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Набиране на участнициФаза 3Здравите доброволци са добре дошли
- ACCOMPLISH-2 Research Site, Ocoee · на 10 мили
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Набиране на участнициФаза 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Набиране на участнициФаза 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Набиране на участнициФаза 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Набиране на участнициФаза 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · на 5 мили
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Набиране на участнициФаза 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Набиране на участнициФаза 3
- ACCOMPLISH-1 Research Site, Ocoee · на 10 мили
Проучвания за Наднормено тегло в други градове
- San Antonio, TX34 проучвания
- Houston, TX33 проучвания
- Chicago, IL28 проучвания
- Las Vegas, NV23 проучвания
- Miami, FL23 проучвания
- Atlanta, GA20 проучвания
- Dallas, TX20 проучвания
- New York City, NY19 проучвания
- Jacksonville, FL19 проучвания
- Washington, DC19 проучвания
- Austin, TX18 проучвания
- Baltimore, MD17 проучвания
Други проучвания в Orlando
- Рак на белия дроб с недребноклетъчен тип44 проучвания
- Затлъстяване31 проучвания
- Метастатичен рак29 проучвания
- Болест на Алцхаймер25 проучвания
- Диабет тип 224 проучвания
- Рак (всички видове)24 проучвания
- Рак на гърдата23 проучвания
- Рак на яйчниците22 проучвания
- Язвенен колит22 проучвания
- Рак на белия дроб21 проучвания
- Колоректален рак19 проучвания
- Голямо депресивно разстройство19 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.